Determinants associated with uncontrolled asthma in Portugal: A national population-based study by Camarinha, C et al.




Determinants  associated  with  uncontrolled  asthma  in
Portugal: A national  population-based  study
C. Camarinhaa,b, M. Fernandesc, V. Alarcãod,e,f, J. Francog, M.E. Manaçasd,
C.  Bárbarah,e, P.J. Nicolaa,e,∗
a Epidemiology  Unit,  Institute  of  Preventive  Medicine  and  Public  Health,  Faculty  of  Medicine,  University  of  Lisbon,  Hospital  de
Santa Maria  Avenida  Professor  Egas  Moniz,  1649-035  Lisboa,  Portugal
b Allergy  Center,  CUF  Descobertas  Hospital,  Rua  Mário  Botas,  1998-018  Lisboa,  Portugal
c CTI  Clinical  Trial  and  Consulting  Services,  Rua  Tierno  Galvan,  Torre  3,  Piso  16,  1070-274  Lisboa,  Portugal
d Institute  of  Preventive  Medicine  and  Public  Health,  Faculty  of  Medicine,  University  of  Lisbon,  Hospital  de  Santa  Maria  Avenida
Professor Egas  Moniz,  1649-035  Lisboa,  Portugal
e Environmental  Health  Institute  (ISAMB),  Faculty  of  Medicine,  University  of  Lisbon,  Hospital  de  Santa  Maria  Avenida  Professor
Egas Moniz,  1649-035  Lisboa,  Portugal
f Centro  de  Investigação  e  Estudos  de  Sociologia  (CIES-IUL)  do  Instituto  Superior  de  Ciências  do  Trabalho  e  da  Empresa  -  Instituto
Universitário de  Lisboa  (ISCTE-IUL),  Av.a das  Forças  Armadas,  1649-026  Lisboa,  Portugal
g Pediatrics  Department,  Hospital  Garcia  da  Orta,  Av.  Torrado  da  Silva,  2805-267  Almada,  Portugal
h Thorax  Department,  Faculty  of  Medicine,  University  of  Lisbon,  Hospital  de  Santa  Maria  Avenida  Professor  Egas  Moniz,  1649-035
Lisboa, Portugal







Introduction  and  objectives:  Asthma  is  a  chronic  and  heterogeneous  disease  that  affects  peo-
ple of  all  ages  and  has  a  high  estimated  increase  in  prevalence  worldwide.  Asthma  control
represents  a  main  goal  in  the  disease  management.  International  studies  revealed  low  levels
of disease  control  resulting  in  a  signiˇcant  burden  for  healthcare  systems,  not  only  in  terms  of
quality of  life,  but  also  in  terms  of  health  costs.  Modiˇable  and  non-modiˇable  factors  have
been identiˇed  as  relating  to  poor  asthma  control  level.  In  this  study  we  evaluated  the  distri-
bution of  asthma  control  levels  in  Portuguese  adult  population  and  examine  the  determinants
associated  with  uncontrolled  asthma.
Materials  and  methods:  Using  a  similar  methodology  to  the  one  employed  in  the  Asthma  Insights)  survey,  327  active  asthmatic  patients  were  identiˇed  by  random
ed  a  questionnaire  during  2011  to  2012.  Asthma  control  was  assessed
 based  symptom  control,  by  Asthma  Control  TestTM (ACT)  and  by
To  examine  the  relationship  between  uncontrolled  asthma  and  itsand Reality  in  Europe  (AIRE
phone number  and  complet
by the  evaluation  of  GINA
self-perception  of  control.  Please  cite  this  article  in  press  as:  Camarinha  C,  et  al.  Pulmonol.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.014
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determinants,  univariate  logistic  regression  analysis,  sequential  multivariable  regression  and
population attributable  risk  percentage  were  determinate.
Results:  35.2%  active  asthmatic  patients  had  uncontrolled  asthma,  64.8%  partially  controlled
and none  of  the  individuals  had  total  control  of  asthma  assessed  by  ACT  test.  Factors  signi-
ˇcantly associated  with  poor  asthma  control  scores  were:  age  (OR  1.02  per  year  of  age;  95%
CI: 1.01--1.03),  female  sex  (OR  1.87;  95%  CI:  1.15--3.04),  educational  level  (OR  0.5;  95%  CI:
0.28--0.89  at  high  school  level  or  over),  occupation  (OR  4.92;  95%  CI:  2.12--11.42  if  looking  for  a
ˇrst job  or  unemployed)  (OR  2.51;  95%  CI:  1.35--4.65  if  being  retired),  income  (OR  0.23;  95%  CI:
0.07--0.72 if  >619  euros),  BMI  (OR  1.09  per  BMI  unit;  95%  CI:  1.03--1.14),  having  rhinitis  symp-
toms (OR  4.40;  95%  CI:  2.56--7.58)  and  using  inhaled  corticosteroids  (OR  0.44;  95%CI:  0.24--0.82
if used  in  the  past  or  never  used).
Looking  for  a  ˇrst  job  or  being  unemployed,  BMI  and  having  rhinitis  symptoms  remained
signiˇcant  after  multivariate  adjustments.
Conclusions:  Uncontrolled  asthma  was  associated  with  several  determinants.  Their  identiˇ-
cation can  contribute  to  improve  asthma  care  both  from  clinical  and  from  public  health
perspectives.
© 2020  Published  by  Elsevier  Espa~na,  S.L.U.  on  behalf  of  Sociedade  Portuguesa  de  Pneumologia.





























































sthma  is  a  chronic  and  heterogeneous  disease1 that  affects
eople  from  all  ages  and  ethnicities  worldwide.2 There  is
n  estimated  a  global  prevalence  of  315  million  people
ith  asthma,3 contributing  with  more  than  23  million  of
isability-Adjusted  Life  Years  (DALYs).4 Asthma  prevalence
as  been  increasing  in  many  countries,  in  parallel  with  the
evelopment  of  urbanization  and  the  adoption  of  modern
ifestyles.5 It  is  estimated  that  by  2025  100  million  of  people
ore  will  have  asthma  worldwide.5
Despite  the  existence  of  treatment  guidelines,  many  indi-
iduals  with  asthma  remain  undertreated  and  uncontrolled,
esulting  in  a  signiˇcant  burden,  not  only  in  terms  of  qual-
ty  of  life,  but  also  in  terms  of  health  costs.2 Health  cost
ssociated  with  asthma  could  be  direct  costs,  like  treat-
ents  and  hospitalizations,  as  well  as  indirect  costs,  due  to
ork  absences  and  premature  death.2 In  2010,  the  yearly
ost  per  asthmatic  adult  patient  in  Europe,  according  to
stimates  from  Accordini  et  al.,6 ranged  from  509D for
 controlled  asthma  patient  to  2281D for  an  uncontrolled
sthma  patient.
The  Global  Initiative  for  Asthma  (GINA)  was  created
n  1993  with  the  objective  of  disseminating  accurate
nformation  about  asthma  and  improving  the  quality  of
sthma  patient  care  worldwide.1 At  present,  according
o  GINA  guidelines,  achieving  and  maintaining  asthma
ontrol  represents  one  of  the  main  goals  for  the  mana-
ement  of  the  disease  and  consists  of  the  evaluation  of
he  control  of  symptoms  and  future  risk  of  unfavourable
utcomes.1
Numerous  factors  such  as  age,  gender,7 comorbidities7,8
sychological  aspects9 and  socioeconomic  determinants10Please  cite  this  article  in  press  as:  Camarinha  C,  et  al.  Pulmon
ave  been  studied  and  reported  as  associated  with  asthma
ontrol.  Behavioural  reasons  such  as  smoking  habits7 or  ther-






A  multiway  and  a  complex  causal  relationship  between
ealth,  education  level,  work  and  income  has  been
eported.  Having  a  chronic  disease  can  be  considered  a
isk  factor  for  employment.  In  Portugal,  66,294  of  potential
roductive  life  years  were  lost  due  to  non-communicable
iseases  (cardiovascular  disease,  diabetes,  cancer  and  res-
iratory  diseases)  in  2013,  according  Organization  for
conomic  Co-operation  and  Development  (OECD).12
The  Portuguese  National  Asthma  Survey  reported  a
roportion  of  43.1%  uncontrolled  disease  in  asthmatic
ortuguese  population.13 In  a national  population  study  non-
odiˇable  factors  such  as  age  and  gender  were  associated
ith  uncontrolled  asthma.14 Self-evaluation  of  uncontrolled
sthma,  participation  in  decisions  related  to  treatment  and
he  presence  of  comorbidities  have  also  been  considered  as
mportant  contributions  to  asthma  control.14
The  purpose  of  this  study  was  to  investigate  the  distribu-
ion  of  asthma  control  level  in  Portuguese  adult  population,
sing  different  approaches  of  control  level  evaluation,  and




 cross-sectional  study  at  national  level  (Portugal)  was  car-
ied  out  from  March  2011  to  March  2012,  based  on  the
ethodology  applied  in  the  Asthma  Insights  and  Reality  in
urope  (AIRE).15
A  probabilistic  sample  of  individuals  diagnosed  with
`active  asthma''  was  identiˇed  through  telephone  numbersol.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.014
nd  a  structured  telephone  interview  was  used.  In  order  to
elect  exclusively  individuals  with  active  asthma,  an  adult
n  each  household  was  asked  the  following  question:  ``Has  a





























A  total  of  327  full  interviews  were  completed  with  adults
who  had  active  asthma.  A  detailed  description  of  the  demo-
Table  1  Respondent  characteristics.
Age,  median  (IQR)  44  (27--58)
Female,  n  (%)  203  (62.1)
Age at  diagnosis  of  asthma,  median  (IQR)  15  (5--36)
Duration  of  asthma  in  years,  median  (IQR)  20  (10--30)
Smoking  habits  (n  =  315)
Non-smoker,  n  (%)  199  (63.2)
Current  smoker,  n  (%)  49  (15.6)
Former  smokers,  n  (%)  67  (21.3)
Body mass  index  (n  =  310)
Underweight,  n  (%)  10  (3.2)ARTICLEPULMOE-1483; No. of Pages 13
Determinants  of  uncontrolled  asthma  
as  having  asthma?''.  Participants  were  included  as  having
active  asthma  if  they  answered  positively  at  least  one  of  the
following  questions:  ``Do  any  of  those  individuals  diagnosed
with  asthma  take  any  medication  for  their  asthma?''  and
``Has  any  of  those  individuals  diagnosed  with  asthma  had
any  asthma  crises  or  asthma  symptoms  in  the  last  year?''.
If  more  than  one  household  member  with  asthma  was  qual-
iˇed,  a  respondent  was  randomly  selected  for  interview.
A  total  of  557  individuals  were  identiˇed  with  active
asthma  and  327  complete  interviews  were  acquired  in  adults
(≥16  years  old).
Control  assessment
Asthma  control  was  evaluated  in  three  ways:  GINA  based
symptom  control,  by  Asthma  Control  TestTM (ACT)  and  indi-
vidual  self-perception  of  control  assessment.
The  asthma  symptom  control,  based  on  GINA,  included
four  questions,  relating  to  the  previous  four  weeks,
about  the  frequency  of  daytime  symptoms,  night  waking,
relief  medication  needs  and  activity  limitations  due  to
asthma.
ACT  is  a  quantitative  self-assessment  tool  for  asthma  con-
trol,  which  consists  of  5  simple  questions  for  the  interviewee
to  consider  on  the  impact  of  asthma  on  a  daily  basis  over
the  previous  four  weeks;  relating  to  shortness  of  breath,
use  of  rescue  medication,  nocturnal  asthma  symptoms  and
self-evaluation  of  asthma  control.16 According  to  Thomas
et  al.17 ACT  scores  equal  to  or  below  19  are  considered
as  identifying  patients  with  poorly  controlled  asthma,  as
deˇned  by  GINA.  ACT  is  also  used  for  the  evaluation  of  deter-
minants  associated  with  poor  asthma  control.  ACT  scores
equal  to  or  below  19  points  correspond  to  ``uncontrolled''
asthma  and  scores  of  at  least  20  points  are  classiˇed  as
``controlled''  (20--24  =  ``partially  controlled'';  25  =  ``totally
controlled'').
From  the  main  questionnaire  of  the  study,  several
determinants  for  the  analysis  were  selected  according
to  their  relevance  and  the  consulted  bibliography:  age,
sex,  civil  status,  region  of  residence,  educational  level,
occupation,  household  income,  body  mass  index  (BMI),
smoking  habits,  rhinitis  symptoms,  allergies  as  a  trigger
for  crises,  having  family  doctor,  assistant  physician  to  solve
asthma  problems,  seasonal  ˚u  vaccination,  Peak  Flow  Metre
use,  conducting  lung  function  tests,  training  to  use  the
inhaler  properly,  written  asthma  action  plan,  forgetting
to  take  medication,  inhaled  corticosteroid  use  and  num-
ber  of  medications  used  for  asthma.  BMI  was  classiˇed
according  to  the  World  Health  Organization  (WHO)  criteria
for  adults,18 being  underweight  if  BMI  <18.5  kg/m2,  pre-
obesity  if  25.0  kg/m2 ≥  BMI  <  30.0  kg/m2,  and  obesity  if  BMI
≥30.0  kg/m2.
Statistical  analysis
Descriptive  statistics  were  described  as  absolute  frequencyPlease  cite  this  article  in  press  as:  Camarinha  C,  et  al.  Pulmon
and  proportion  for  categorical  variables  and  continuous
variables  were  represented  as  mean  (standard  deviation)  for
normally  distributed  variables  and  as  median  (interquartile
range)  for  non-normally  distributed  variables. PRESS
3
The  age  differences  between  sexes  was  evaluated  by  the
ann  Whitney  U  Test.
For  additional  analyses  two  groups  of  active  asthma
espondents  were  considered:  controlled  (ACT  score  ≥20)
nd  uncontrolled  (ACT  score  ≤19).
To  examine  the  relationship  between  uncontrolled
sthma  and  its  determinants,  an  indicator  of  uncontrolled
sthma  was  used  as  a  dependent  variable.  The  determinants
ere  classiˇed  into  the  following  domains,  grouping  concep-
ually  related  variables:  demographic,  socioeconomic,  risk
nd  clinical  factors,  clinical  care  and  treatment.  Univariate
ogistic  regression  analysis  was  done  for  all  determinants.
rom  a  public  health  perspective  and  in  order  to  measure
he  contribution  of  each  determinant  to  the  level  of  asthma
ontrol,  the  population  attributable  risk  percentage  (PAR%)
as  assessed,  using  the  following  formula:
AR% =  [Pe  ×  (OR  −  1)/[(1  +  Pe  ×  (OR  −  1)]]  ∗  100
(Pe  =  estimate  of  population  exposure)
with  OR  as  the  inverse  risk  (1/OR)  in  the  case  of  a  pro-
ective  factor  (odds  ratio  lower  than  1).
Sequential  multivariable  regression  was  performed.
ariables  with  p  <  0.30  in  the  univariate  analysis  were  used
o  build  the  adjusted  models  (Forward  Likelihood  Ratio
ethod).  Multivariable  adjustments  were  performed  in
equence  considering  additions  to  variables  for  the  differ-
nt  domains,  where  variables  from  a given  domain  were
djusted  to  the  multivariable  model,  as  noted  in  the  Table  4.
seudo  r-squared  (Cox  and  Nagelkerke)  were  calculated
rom  the  models  originated.
For  all  tests  performed,  the  level  of  statistical  signiˇ-
ance  was  set  at  0.05.  All  analyses  were  conducted  using
PSS  version  23  (IBM  Corp.,  Armonk,  N.Y.,  USA).
esultsol.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.014
Normal  weight,  n  (%)  138  (44.5)
Pre-obesity,  n  (%)  115  (37.1)
Obesity,  n  (%)  47  (15.2)
IQR: interquartile range.
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Table  2  Asthma  control  assessment.
GINA  based  symptom  control
Controlled,  n  (%)  112  (34.3)
Partly  controlled,  n  (%)  156  (47.7)
Uncontrolled,  n  (%)  59  (18.0)
ACT score
Controlled  asthma  (ACT  =  25),  n  (%)  0
Partially  controlled  (ACT  20--24),  n  (%)  212  (64.8)
Non-controlled  asthma  (ACT  ≤19),  n  (%)  115  (35.2)
Patient  perceived  control
Completely  controlled,  n  (%) 84  (25.7)
Well controlled,  n  (%) 145  (44.3)

























































































Poorly  controlled,  n  (%)  18  (5.5)
Not controlled  at  all,  n  (%)  2  (0.6)
raphic  and  asthma  related  variables  is  summarized  in
able  1.  Further  socioeconomic,  risk  and  clinical  factors,
s  well  as  clinical  care  and  treatment  characteristics  are
escribed  below.
In  the  sampled  population,  62.1%  were  female  and  37.9%
ale.  In  female  the  median  age  was  46  (29--58)  and  in  male
7.5  (26--56),  without  statistic  signiˇcant  differences.  A  high
ercentage  of  the  individuals  questioned  was  pre-obese  or
bese  (52.3%)  and  36.9%  were  ever  smokers.
sthma  control
requency  of  self-reported  symptoms  (in  the  last  four
eeks)  is  discriminated  in  Fig.  1.
In  relation  to  GINA  based  symptoms  control  assessment,
f  the  327  adult  individuals  interviewed,  18%  had  uncon-
rolled  asthma,  47.7%  partially  controlled  and  34.3%  had
otally  controlled.  Based  on  ACT  test,  35.2%  of  the  sub-
ects  had  uncontrolled  asthma,  64.8%  partially  controlled
nd  none  of  the  individuals  had  total  control.  93.9%  of  the
ndividuals  perceived  their  asthma  as  completely,  well  or
omewhat  controlled  and  only  6.1%  perceived  their  asthma
oorly  or  not  controlled  at  all  (Table  2).
Concerning  the  agreement  between  ACT  asthma  control
core  and  the  participants'  self-perception,  about  39.2%  of
ndividuals  with  uncontrolled  asthma  evaluated  by  ACT  self-
eported  their  asthma  as  completely  or  well  controlled  and
nly  16.5%  had  the  self-perception  that  agreed  with  the
bjective  assessment  of  asthma  control.
eterminants  for  uncontrolled  asthma
e  then  sought  to  understand  which  factors  were  associated
ith  poor  asthma  control.  In  a  univariate  analysis,  the  fac-
ors  signiˇcantly  associated  with  poor  asthma  control  scores
ACT  score  ≤19)  were:  age,  female  sex,  educational  level
<high  school  level),  occupation  (looking  for  a  ˇrst  job,  being
nemployed  or  being  retired),  income  (<619  euros),  higherPlease  cite  this  article  in  press  as:  Camarinha  C,  et  al.  Pulmon
MI  (obesity),  having  rhinitis  symptoms  and  using  inhaled
orticosteroids.  In  contrast,  civil  status,  region  of  residence,
moking  habits,  allergies  as  a  trigger  for  the  crisis,  having
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sthma  problems,  seasonal  ˚u  vaccine,  peak  ˚ow  metre
se,  lung  function  tests  performance,  training  to  use  the
nhaler  properly,  written  asthma  action  plan,  forgetting  to
ake  medication  and  number  of  medications  used  for  asthma
ere  not  statistically  signiˇcant  determinants  in  the  univari-
te  analysis  (Table  3).  The  PAR%  for  the  signiˇcant  variables
re  also  in  Table  3. In  order  to  understand  the  relationship  of
igniˇcant  variables  in  the  univariate  analysis  a  sequential
ultivariable  adjustment  analysis  was  performed  by  adding
he  dimensions  of  factors  sequentially  (Table  4).  Occupa-
ion,  BMI  and  having  rhinitis  symptoms  were  the  factors  that
emained  statistically  signiˇcant  results  besides  the  sequen-
ial  adjustments.
Individuals  over  age  of  65  had  2.70  (95%  CI:  1.21--5.99)
imes  higher  odds  for  having  uncontrolled  asthma  compared
o  the  youngest  group  analyzed  (16--25  years)  and  PAR%  value
f  19.3%.  It  appears  that  there  is  a  progressive  increase;
ith  each  year  of  age  the  chance  of  uncontrolled  asthma
ncreases  by  2%  and  female  gender  increases  the  odds  of
ncontrolled  asthma  by  1.87  (95%  CI:  1.15--3.04).  However
ocioeconomic  determinants  (occupation)  seems  to  attenu-
te  these  associations.
Regarding  socioeconomic  determinants:  the  increase  in
ducation  level  decreases  the  odds  of  having  uncontrolled
sthma  (OR  0.5  high  school  level  or  more);  higher  income
ecreases  the  odds  of  uncontrolled  asthma;  in  relation  to
ccupation,  subjects  looking  for  a  ˇrst  job  or  unemployed
ad  4.92  higher  odds  for  uncontrolled  asthma  scores  (95%
I:  2.12--11.42)  and  being  retired  is  associated  with  2.51
dds  (95%  CI:  1.35--4.65)  for  uncontrolled  asthma,  when
ompared  with  employed  asthmatics.  The  protective  role
f  educational  level  and  income  seems  to  be  mediated  by
isk  and  clinical  factors  (BMI  and  having  rhinitis  symptoms).
articipants  looking  for  a  ˇrst  job  or  who  were  unemployed
ad  PAR%  value  of  26.8%  and  were  much  more  likely  to
ave  uncontrolled  asthma  regardless  of  the  various  adjusted
imensions.
For  each  kg/m2 increment  of  BMI  the  chance  of  uncon-
rolled  asthma  increased  9%,  this  association  remained
igniˇcant  even  when  dimensions  adjustments  were  consid-
red.  PAR%  of  uncontrolled  asthma  associated  with  obesity
as  23.5%.
Nasal  symptoms  were  the  symptoms  identiˇed  as  occur-
ing  almost  every  day  in  the  previous  four  weeks  (Fig.  1).
aving  rhinitis  symptoms  increases  the  odds  of  uncontrolled
sthma  by  4.4  (95%  CI:  2.56--7.58).  These  associations
emained  signiˇcant  regardless  of  the  adjustments  consid-
red.  The  PAR%  of  uncontrolled  asthma  associated  with
hinitis  symptoms  was  65.9%.
Clinical  factors,  such  as  smoking  habits  and  having
llergies  as  a  trigger  for  asthma  crisis,  were  not  signiˇ-
antly  associated  with  uncontrolled  asthma.  Also,  in  this
nalysis,  the  determinants  related  to  clinical  care  did
ot  demonstrate  signiˇcant  associations.  Of  the  treatment
eterminants  evaluated  (forgetting  to  take  medication,
he  number  of  medications  used  for  asthma  and  the  use
f  inhaled  corticosteroids)  individuals  not  using  inhaled
orticosteroids  had  signiˇcantly  lower  odds  for  uncon-
rolled  asthma  (OR  0.44  95%  CI:  0.24--0.82),  but  it  seems
hat  the  effect  is  mediated  by  the  risk  factors  and  theol.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.014




















































Table  3  Univariate  analysis  for  uncontrolled  asthma  and  Population  attributable  risk  %.
Determinants  All  participants
n (%)
Uncontrolled
asthma  n  (%)
Risk  for  uncontrolled
asthma  (ACT  score  ≤  19)
Population
attributable  risk  %
Crude  Odds  Ratio  (95%  CI) p  Value
Demographic
Age,  classes 16--25 67  (20.5%) 17  (14.8%) ref
26--45 105  (32.1%) 34  (29.6%) 1.41  (0.71--2.80) 0.327  --
46--65 109 (33.3%) 42  (36.5%) 1.84  (0.94--3.61) 0.074  --
> 65 46  (14.1%) 22  (19.1%) 2.70  (1.21--5.99) 0.015  19.3%
Age, years 44  (27--58)a 47.69  (18.7)b 1.02  (1.01--1.03) 0.005  --
Sex Male  124  (37.9%) 33  (28.7%) ref  0.012
Female 203  (62.1%) 82  (71.3%) 1.87  (1.15--3.04) 35.1%
Civil status Single  106  (33.0%) 34  (29.8%) ref
Married  or  Cohabited 174  (54.2%) 62  (54.4%) 1.17  (0.70--1.96) 0.543  --
Divorced, separated  or
Widow  (er)
41  (12.8%) 18  (15.8%) 1.66  (0.79--3.47) 0.181  --
Region of  residence Lisboa  e  Vale  do  Tejo 106  (33.3%) 38  (34.5%) ref
Alentejo  e  Algarve 32  (10.1%) 9  (8.2%) 0.70  (0.29--1.67) 0.42  --
Centro 63  (19.8%) 17  (15.5%) 0.66  (0.33--1.31) 0.236  --
Acores 12 (3.8%) 4  (3.6%) 0.90  (0.25--3.17) 0.863  --
Madeira 10  (3.1%) 6  (5.5%) 2.68  (0.71--10.11) 0.144  --
Norte 95  (29.9%) 36  (32.7%) 1.09  (0.62--1.94) 0.764  --
Socioeconomic
Educational level 3rd  cycle  of  basic
education  or  less
132  (42.0%) 63  (56.3%) ref
High  school 80  (25.5%) 25  (22.3%) 0.50  (0.28--0.89) 0.019  20.3%
Post-secondary
education or  more
102  (32.5%) 24  (21.4%) 0.34  (0.19--0.60) <0.001  38.7%
Occupation Employed  158  (51.0%) 44  (40.0%) ref
Student  54  (17.4%) 13  (11.8%) 0.82  (0.4--1.68) 0.59  --
Domestic 10  (3.2%) 5  (4.5%) 2.59  (0.72--9.39) 0.147  --
Looking for  a  ˇrst  job  or
Unemployed
29  (9.4%) 19  (17.3%) 4.92  (2.12--11.42) <0.001  26.8%
Retired 59 (19.0%) 29  (26.4%) 2.51  (1.35--4.65) 0.004  22.3%
Income <340  Euros 16  (7.0%) 11  (12.6%) ref
340--618  Euros 46  (20.1%) 26  (29.9%) 0.59  (0.18--1.98)  0.393  --
619--1531 Euros 92  (40.2%) 31  (35.6%) 0.23  (0.07--0.72) 0.012  57.4%
1532--3522 Euros 59  (25.8%) 17  (19.5%) 0.18  (0.06--0.61)  0.006  54.0%

















































Table  3  (Continued)
Determinants  All  participants
n  (%)
Uncontrolled
asthma  n  (%)
Risk  for  uncontrolled
asthma  (ACT  score  ≤  19)
Population
attributable  risk  %
Crude  Odds  Ratio  (95%  CI)  p  Value
Risk  and  clinical  factors
Body  mass  index  (BMI)  Normal  weight  138  (44.5%)  40  (37.4%)  ref
Underweight  BMI
(kg/m2)  <18.50
10  (3.2%)  3  (2.8%)  1.05  (0.26--4.27)  0.946  --
Pre--obesity BMI  (kg/m2)
≥25.0  and  <30.0
115  (37.1%)  38  (35.5%)  1.21  (0.71--2.06)  0.487  --
Obesity BMI  (kg/m2)
≥30.0
47  (15.2%)  26  (24.3%)  3.03  (1.53--6.00)  0.001  23.5%
Body mass  index  (BMI),
kg/m2
25.2  (22.1--28.3)a 26.3  (23.5--29.7)a 1.09  (1.03--1.14)  0.001  --
Smoking habits  Current  smoker  49  (15.6%)  18  (15.9%)  ref
Former smokers  67  (21.3%)  19  (16.8%)  0.68  (0.31--1.50)  0.34  --
Non--smoker 199  (63.2%)  76  (67.3%)  1.06  (0.56--2.03)  0.851  --
Having rhinitis
symptoms
No  118  (43.2%)  25  (22.9%)  ref  <0.001
At least  1  or  2  days  a
week
155  (56.8%)  84  (77.1%)  4.40  (2.56--7.58)  65.9%
Allergies as  a  trigger
for the  crisis
No  72  (22.0%)  29  (25.2%)  ref
Yes 255  (78.0%)  86  (74.8%)  0.76  (0.44--1.29)  0.305  --
Clinical care
Family  doctor  Having  262  (81.6%)  97  (85.1%)  ref  0.236
Not having  59  (18.4%)  17  (14.9%)  0.69  (0.37--1.28)  --
Assistant physician  to
solve  asthma  problems
Family  doctor/General
clinic
151  (46.5%)  54  (47.8%)  ref
Pneumologist  48  (14.8%)  18  (15.9%)  1.08  (0.55--2.11)  0.827  --
Allergologist  78  (24%)  21  (18.6%)  0.66  (0.36--1.21)  0.178  --
Emergency Care  32  (9.8%)  15  (13.3%)  1.59  (0.73--3.42)  0.241  --
Other 16  (4.9%)  5  (4.4%)  0.82  (0.27--2.47)  0.72  --
Taking the  seasonal  ˚u
vaccine
Yes  130  (40.6%)  53  (46.1%)  ref  0.137



















































Table  3  (Continued)
Determinants  All  participants
n (%)
Uncontrolled
asthma  n  (%)
Risk  for  uncontrolled
asthma  (ACT  score  ≤  19)
Population
attributable  risk  %
Crude  Odds  Ratio  (95%  CI) p  Value
Use  the  Peak  Flow
Metre
Never  264  (88.6%) 96  (91.4%) ref  0.259




34  (11.4%) 9  (8.6%) 0.63  (0.28--1.41) --
Perform lung  function
tests  (past  12  months)
At  least  every  six  months
or  at  all  Doctor
appointment
105  (43.8%) 36  (40.9%) ref
Only once 116  (48.3%) 46  (52.3%) 1.26  (0.73--2.18) 0.410  --
Never 19  (7.9%) 6  (6.8%) 0.89  (0.31--2.52) 0.819  --
Have training  to  use
the  inhaler  properly
Yes  253  (79.8%)  90  (81.1%)  ref  0.679
No 64  (20.2%)  21  (18.9%)  0.88  (0.49--1.58)  --
Patients having  a
written  asthma  action
plan
Yes  77  (24.9%)  23  (21.3%)  ref  0.281
No 232  (75.1%)  85  (78.7%)  1.36  (0.78--2.37)  --
Treatment
Forgetting to  take
medication
Yes 52  (33.3%) 19  (26.8%) ref  0.113
No 104  (66.7%) 52  (73.2%) 1.74  (0.88--3.44) --
Under inhaled
corticosteroid
Using  63  (31%) 31  (42.5%) ref  0.009
Used in  the  past  or  never
used
140  (69%) 42  (57.5%) 0.44  (0.24--0.82) 46.7%
Number of  asthma
medication
None  or  one  medication  162  (49.5%)  49  (42.6%)  ref  0.065
Two or  more  medications  165  (50.5%)  66  (57.4%)  1.54  (0.97--2.43)  --
CI: Conˇdence Interval; ref: reference.
Data shown in this table exclude missing values and answers ``do not know/do not respond''.
a Median (interquartile range).

















































Table  4  Multivariable  analysis  for  uncontrolled  asthma  with  sequential  dimensions  adjustments.
Determinants  Adjusted  to  A  Adjusted  to  A  +  B  Adjusted  to  A  +  B  +  C
Adjusted  OR  (95%  IC)  P  value  Adjusted  OR  (95%  IC)  P  value  Adjusted  OR  (95%  IC)  p  value
Demographic  (A)
Age  1.02  (1.00--1.03)  0.01  /  /
Sex Male  Ref  /  /
Female 1.77  (1.08--2.90)  0.023
Socioeconomic  (B)
Educational  level  3rd  cycle  of  basic
education  or  less
Ref  /
High school  0.61  (0.31--1.22)  0.16  0.67  (0.33--1.34)  0.255
Post-secondary
education  or  more
0.38  (0.21--0.72)  0.003  0.47  (0.24--0.90)  0.023
Occupation Employed  Ref  ND
Student  0.92  (0.41--2.06)  0.831  0.75  (0.32--1.74)  0.498
Domestic 1.98  (0.51--7.61)  0.322  5.09  (0.54--47.96)  0.155
looking for  a  ˇrst  job
or  unemployed
4.55  (1.95--10.63)  <0.001  6.05  (2.21--16.57)  <0.001
Retired 2.11  (0.90--4.93)  0.084  1.71  (0.79--3.69)  0.171
Income <340  Euros  Ref  /
340--618 Euros  0.78  (0.23--2.68)  0.692  0.73  (0.19--2.90)  0.66
619--1531 Euros  0.35  (0.11--1.15)  0.084  0.36  (0.09--1.40)  0.14
1532--3522  Euros  0.27  (0.08--0.93)  0.038  0.32  (0.08--1.31)  0.112
>3523 0.13  (0.02--0.87)  0.035  0.12  (0.02--0.88)  0.037
Risk and  clinical  factors  (C)
Body  mass  index  (BMI)  1.07  (1.02--1.13)  0.008  1.07  (1.01--1.13)  0.017  1.09  (1.02--1.16)  0.012
Having rhinitis  symptoms  No  Ref
at least  1  or  2  days  a
week
4.63  (2.64--8.11)  <0.001  4.49  (2.49--8.10)  <0.001  4.71  (2.52--8.81)  <0.001
Treatment (E)
Under  inhaled  corticosteroid  Using  Ref  /
used in  the  past  or
never  used
0.48  (0.25--0.89)  0.02  0.49  (0.26--0.94)  0.032
CI: Conˇdence Interval; Ref: Reference.
ND: not determinate because A + B adjustment is occupation.
/: not represented because p values >0.05.
A: Age and Sex; R2 Cox = 0.040 and Nagelkerke = 0.055.
A + B: Occupation; R2 Cox = 0.074 and Nagelkerke 0.101.
A + B + C: Occupation, IMC and Having rhinitis symptoms; R2 Cox = 0.201 and Nagelkerke = 0.272.
The following adjusted models A + B + C + D and A + B + C + D + E didn't add any of the determinants considered in Clinical Care or Treatment and are not presented in this table.
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Figure  1  Frequency  of  self-reported  symptoms
Discussion
This  study  showed  that  64.8%  subjects  had  their  asthma
controlled,  and  35.2%  of  them  had  uncontrolled  asthma,
according  to  the  evaluation  of  a  questionnaire  for  asthma
control  purpose,  the  ACT.
Evaluation  of  asthma  control  has  been  assessed  in  diverse
countries  worldwide  and  despite  the  different  measurement
tools  used,  a  sub-optimal  level  of  control  has  been  revealed.
Results  from  a  multinational  study  involving  twelve
countries  of  Europe  (n  =  3.123),  indicate  a  similar  overall
percentage  (38.5)  for  uncontrolled  asthma,  with  the  lowest
levels  of  asthma  control  found  in  Hungary,  The  Netherlands
and  France.7 Higher  levels  of  uncontrolled  asthma  (71.3%)
were  found  in  surveyed  African  countries  (Algeria,  Morocco,
and  Tunisia),19 USA  (71%),20 Asia-Paciˇc  countries  (92.4%)21
and  Latin  America  (93%).22
From  a  national  perspective,  the  Portuguese  National
Asthma  Survey  using  Control  of  Allergic  Rhinitis  and  Asthma
Test  (CARAT),  reported  43.1%  of  uncontrolled  asthma  in  Por-
tuguese  population.13 In  2007,  a  study  in  a  central  hospital
in  Lisbon  using  the  ACT  questionnaire  in  the  context  of
allergology  consultation  found  that  23.3%  of  the  respon-
dents  presented  ACT  values  ≤1911 and  a  study  carried  out
in  Portuguese  pharmacies,  with  the  application  of  the  same
questionnaire  to  evaluate  the  control,  revealed  even  higher
scores  for  poor  asthma  control  (61.2%).23
In  this  study  it  was  possible  to  observe  that  the  level
of  control  assessed  can  differ  with  the  asthma  control  tool
utilized.  The  different  methodologies  that  can  be  used  in
epidemiological  studies  such  as  in  clinical  practice  for  con-
trol  assessment  [e.g.,  GINA  based  symptom  control  tool1;
CARAT24;  Asthma  Control  Questionnaire  (ACQ)25;  ACT16] can
make  it  more  difˇcult  to  compare  results  between  stud-
ies.  Additionally,  there  are  different  approaches  used  to
gather  information  (e.g.  telephone  interview,  online  ques-
tionnaire,  face-to-face  interview),  several  methods  used  to
assess  asthma  control  level  and  different  situations  in  differ-
ent  health  systems,  literacy  and  social  barriers  among  the
different  countries;  all  of  which  should  be  taken  into  con-
sideration  when  comparing  results  from  different  studies.Please  cite  this  article  in  press  as:  Camarinha  C,  et  al.  Pulmon
Most  of  the  adult  patients  interviewed  overestimated
their  disease  control  revealing  a  discrepancy  between
patient  perception  of  asthma  control  and  the  objective





he  last  four  weeks),  as  cumulative  percentages.
heir  asthma  with  some  level  of  control.  It  has  been
hown  that  most  of  these  patients  can  tolerate  their  symp-
oms  and  lifestyle  limitations  as  inevitable  consequences  of
he  disease.26 The  self-perception  and  expectations  about
sthma  disease  may  result  in  misinterpretations  of  control
evel.26
In  terms  of  demographic  factors,  our  results  indicate  that
ncontrolled  asthma  was  more  frequently  associated  with
lder  age  and  with  female  sex.
Asthma  disease  in  the  elderly  population  is  of  special
oncern  since  most  of  patients  are  polypathological  and
olymedicated,  which  can  have  a  negative  impact  on  disease
anagement.27 Besides,  there  are  often  more  difˇculties
n  the  execution  of  proper  inhaler  techniques.27,28 Kämpe
t  al.29 stated  that  uncontrolled  asthma  was  more  common
n  older  groups  (≥65years);  Mendes  et  al.,23 using  a  Por-
uguese  population,  found  that  69%  of  elderly  (>70  years)
ad  uncontrolled  asthma.
Our  results  observing  the  association  between  sex
nd  poor  asthma  control,  are  in  agreement  with  other
tudies,23,29,30 with  females  associated  with  poor  scores  in
sthma  control.  Usually  women  perceive  asthma  differently
rom  men,  reporting  higher  levels  of  symptoms  and  more
imitations  in  day-to-day  life.31,32 In  addition,  women  have
een  associated  with  a  higher  incidence  of  later  asthma
nset  and  a  higher  prevalence  of  non-allergic  asthma  phe-
otype,  favouring  a  less  effective  response  to  corticosteroid
reatments.1,33,34
In  this  study,  socioeconomic  determinants,  especially
ccupation  have  a  considerable  association  with  poor  con-
rol  score  of  asthma  as  well  as  greater  in˚uence  on  other
mportant  determinants.  The  PAR%  for  being  looking  for
 ˇrst  job  or  being  unemployed  was  26.8%,  suggesting
 very  signiˇcant  contribution  for  poor  asthma  control.
oreover  studies  identiˇed  that  the  severity  of  asthma,35
he  frequency  of  asthma  symptoms  and  night  awakenings
ecause  of  asthma  can  contribute  to  work  disability  and
nemployment.36
The  inverse  association  between  income37 and
ducation29 with  poor  controlled  asthma  outcomes  has
een  documented.  The  PAR%  register  for  having  at  leastol.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.014
ost-secondary  education  was  38.7%  suggesting  a  contribu-
ion  for  preventing  worse  levels  of  control  in  asthma.  The
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Individuals  with  higher  levels  of  education  can  have  a  bet-
er  understanding  of  the  prescribed  therapeutics  and  may
ave  a  greater  tendency  to  adhere  to  treatment  regime.29
urthermore,  there  are  work  environments  associated  with
rigger  agents  exposure  (e.g.,  diisocyanates,  acrylates  or
leaning  agents)38 to  which  individuals  with  higher  educa-
ional  levels  are  less  likely  to  be  exposed.29
Although  only  8.8%  of  the  individuals  considered  that  the
rice  of  asthma  treatments  in˚uenced  taking  medication
ccording  medical  indications,  asthma  expenses  related  to
edical  treatments  are  usually  high  which  can  be  a  signif-
cant  burden  for  low-income  families,39,40 and  in  turn  can
ompromise  treatment  adherence.
Higher  BMI  was  shown  to  be  associated  with  uncontrolled
evels  in  asthma,  as  stated  above:  Lessard  et  al.41 found
hat  regardless  of  a  similar  perception  of  symptoms,  obese
ndividuals  had  poorer  asthma  control  than  non-obese  asth-
atics;  Lavoie  et  al.42 in  a  382  adults  study  found  that
atients  with  higher  BMI  had  poor  asthma  control  (scored
igher  in  ACQuestionnaire)  independent  of  their  age,  sex
nd  asthma  severity;  with  an  odds  ratio  of  2.99  (95%  CI
.14--7.08)  Ferreira  et  al.11 reported  that  obesity  is  a  factor
ssociated  with  non-control  of  asthma.
Obesity  has  a  negative  impact  on  overall  breathing
echanisms,43 has  been  reported  as  a  risk  factor  for  the
evelopment  of  asthma  and  for  increasing  exacerbations  and
ospitalizations.44 The  pro-in˚ammatory  characteristics  of
besity  can  induce  more  difˇculties  in  asthma  control,  sec-
ndary  to  a  reduction  in  the  response  to  corticosteroids.45
Weight  loss  has  been  shown  to  improve  lung  function
arameters  in  individuals  with  obesity  and  better  scores  of
isease  control  in  asthma  patients.44,46 In  this  way,  nutri-
ional  education  promoting  diet  modiˇcation  and  weight
oss  in  obese  asthmatic  patients  must  be  encouraged.47
ccording  to  our  results  a  considerable  number  of  individu-
ls  (PAR%  =  23.5%)  with  uncontrolled  asthma  could  be  spared
f  obesity  was  not  present.
Findings  from  studies11,48--50 conclude  that  rhinitis  is  an
mportant  contributor  to  a  non-optimal  asthma  control
evel,  as  also  was  supported  by  our  results.  Bousquet  et  al.51
n  a  multivariate  analysis  found  that  patients  with  simulta-
eous  asthma  and  allergic  rhinitis  are  associated  with  higher
evels  of  acute  exacerbations  (OR  1.35,  95%  CI:  1.03--1.77)
ith  more  emergency  visits  (OR  2.35,  95%  CI:  1.12--4.80).
The  PAR%  register  for  having  rhinitis  symptoms  in  our
tudy  (65.9%)  suggests  that  controlling  nasal  symptoms  could
ontribute  positively  to  preventing  worse  levels  of  control
n  asthma  disease.  Consequently,  it  is  important  to  optimize
he  treatment  of  both  diseases  in  patients  with  a  concomi-
ant  diagnosis.52
The  presence  of  smoking  habits  was  not  observed  to  be
 determinant  associated  with  poor  asthma  control  in  our
tudy,  as  already  stated.30,53 In  this  regard,  other  studies
lso  did  not  identify  smoking  as  an  independent  risk  factor
or  uncontrolled  asthma11 or  for  decline  in  lung  function  in
sthmatic  patients54 which  could  be  related  to  a  healthy
moker  effect,55 underestimating  the  effect  of  tobacco  at
ulmonary  level.Please  cite  this  article  in  press  as:  Camarinha  C,  et  al.  Pulmon
Nor  was  an  association  found  with  determinants  of  poor
sthma  control  that  have  been  reported  in  other  studies,
uch  as  patients  having  a  written  asthma  action  plan56 and
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iduals  have  reported  allergies  as  a  trigger  for  asthma  crises
78%),  a  signiˇcant  association  with  uncontrolled  asthma
as  not  detected,  which  is  similar  to  that  reported  by  other
esearch.11,53
Lung  function  assessment  with  peak  ˚ow  metre  or  lung
unction  tests  were  not  signiˇcant  determinants  for  asthma
ontrol  in  our  study.  However  minimizing  air˚ow  limitation  is
ne  of  the  main  goals  for  these  patients  and  the  importance
f  these  exams  in  diagnosis  and  follow-up  of  asthma  has  been
tressed.1
The  use  of  inhaled  corticosteroid  plays  an  important  role
n  an  asthma  treatment  plan.1 Rabe  et  al.15 reported  that  the
se  of  inhaled  corticosteroids  was  low  even  among  patients
ith  severe  persistent  symptoms.  In  our  study,  the  use  of
hese  medications  was  associated  with  lower  ACT  scores,
hich  represents  worse  control  outcomes.  This  association
ith  the  level  of  control  could  be  explained  by  the  rela-
ion  of  treatment  plan  with  disease  severity.  For  example,
atients  with  mild  asthma  degree  and  well  controlled  symp-
oms  might  only  be  at  step  1  of  treatment  plan  and  only  using
 reliever  inhaler  as  needed,  as  was  deˇned  before  2019
INA  guidelines.1 However,  severe  asthma  patients  may
resent  corticosteroid  resistance,57 of  which  the  molecular
athophysiology  is  beginning  to  be  understood,58 leading  to
he  possibility  of  development  of  new  treatments  for  these
atients.
trength  and  limitations
here  are  some  limitations  to  this  study  that  should  be
onsidered:  (1)  it  is  a  cross-sectional  study  and  cause-
ffect  relationships  cannot  be  established;  (2)  all  the
ata  was  reported  by  respondents  and  could  not  be  clini-
ally  conˇrmed;  (3)  only  patients  with  active  asthma  were
uestioned,  excluding  undiagnosed  individuals  and  patients
ithout  the  presence  of  symptoms  and  without  medica-
ion  in  the  last  year;  (4)  this  study  did  not  inquire  about
omorbidities,  such  as:  other  respiratory  disease  which  have
een  associated  to  asthma  control  [e.g.  Chronic  Obstruc-
ive  Pulmonary  Disease  (COPD),  obstructive  sleep  apnoea,
astroesophageal  re˚ux  disease  (GERD),  or  psychological
spects]59; (5)  the  degree  of  asthma  severity,  according  to
INA  guidelines,  was  not  assessed.
A  strength  of  this  study  was  the  identiˇcation  of  active
sthmatic  patients  from  the  general  population  without
eferral  bias.  It  was  also  important  to  evaluate  different
ethods  of  accessing  data  from  the  level  of  asthma  con-
rol  and  the  analysis  of  multiple  factors  and  dimensions  that
ould  have  in˚uenced  the  level  of  control  of  this  important
hronic  disease.
onclusions
n  this  study  uncontrolled  asthma  was  associated  with
everal  factors:  age,  sex,  educational  level,  occupation,
ncome,  BMI,  having  rhinitis  symptoms  and  use  of  inhaledol.  2020.  https://doi.org/10.1016/j.pulmoe.2020.02.014
orticosteroids  as  part  of  a  treatment  plan.  Some  of  these
actors  remain  associated  after  full  adjustment,  notably
ccupation,  BMI  and  having  rhinitis  symptoms,  which  are
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The  values  of  PAR%  for  unemployment,  obesity  and  rhini-
tis  symptoms  were  relatively  high  (respectively  26.8%,  23.5%
and  65.9%).  Since  these  are  modiˇable  factors  from  the  point
of  view  of  public  health  and  health  planning,  intervention
strategies  more  directed  to  these  concerns  can  promote
beneˇts  for  asthmatic  patients  and  consequently  for  other
health  problems.  Similarly,  their  identiˇcation  by  physicians
could  contribute  to  a  better  clinical  approach  to  asthma
disease.
In  future  research  there  should  longitudinal  studies  to
conˇrm  these  associations  and  other  comorbidities,  such
as  COPD  or  GERD  and  enquiries  made  about  physiologi-
cal  factors.  It  is  also  important  to  standardize  a  tool  for
asthma  control  evaluation  that  can  be  used  in  epidemi-
ological  studies  and  that  can  provide  reliable  comparison
between  studies.
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